Editorial
World J Gastroenterol
31(10):101838.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.101838
Abstract (475)
|
Core Tip (548)
|
Full Article (HTML) (2065)
|
Full Article (PDF)-378K (157)
|
Full Article with Cover (PDF)-633K (142)
|
Full Article (XML)-71K (97)
|
Audio-3309K (53)
|
Peer-Review Report-245K (89)
|
Answering Reviewers-157K (101)
|
Received: 09/28/2024
|
Revised: 01/23/2025
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (4825)
|
Similar Articles (160)
|
Timeline of Article Publication (9)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Review
Overcoming antibiotic-resistant Helicobacter pylori infection: Current challenges and emerging approaches
World J Gastroenterol
31(10):102289.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102289
Abstract (656)
|
Core Tip (541)
|
Full Article (HTML) (11095)
|
Figures (1-1) (524)
|
Tables (1-3) (502)
|
Full Article (PDF)-4025K (564)
|
Full Article with Cover (PDF)-4275K (250)
|
Full Article (XML)-507K (108)
|
Audio-1047K (33)
|
Peer-Review Report-271K (122)
|
Answering Reviewers-120K (130)
|
Received: 10/13/2024
|
Revised: 11/28/2024
|
Accepted: 01/17/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (28)
|
Total Visits (17044)
|
Similar Articles (333)
|
Timeline of Article Publication (14)
|
Authors Evaluation (8)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
World J Gastroenterol
31(10):103454.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103454
Abstract (434)
|
Core Tip (469)
|
Full Article (HTML) (2441)
|
Figures (1-1) (388)
|
Full Article (PDF)-1122K (160)
|
Full Article with Cover (PDF)-1376K (150)
|
Full Article (XML)-113K (96)
|
Audio-412K (24)
|
Peer-Review Report-223K (95)
|
Answering Reviewers-109K (81)
|
Received: 11/20/2024
|
Revised: 12/31/2024
|
Accepted: 02/11/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (6443)
|
Similar Articles (1890)
|
Timeline of Article Publication (10)
|
Authors Evaluation (8)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Control Study
Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes
World J Gastroenterol
31(10):103716.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103716
Abstract (480)
|
Core Tip (530)
|
Full Article (HTML) (2075)
|
Figures (1-1) (371)
|
Tables (1-6) (372)
|
Full Article (PDF)-876K (138)
|
Full Article with Cover (PDF)-1130K (168)
|
Full Article (XML)-191K (112)
|
Audio-454K (28)
|
Peer-Review Report-229K (89)
|
Answering Reviewers-124K (77)
|
Supplementary Material-657K (93)
|
Received: 11/27/2024
|
Revised: 01/16/2025
|
Accepted: 02/12/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (6925)
|
Similar Articles (91)
|
Timeline of Article Publication (9)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Endoscopic full-thickness resection: A definitive solution for local complete resection of small rectal neuroendocrine neoplasms
World J Gastroenterol
31(10):100444.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100444
Abstract (507)
|
Core Tip (543)
|
Full Article (HTML) (1892)
|
Figures (1-4) (393)
|
Tables (1-3) (392)
|
Full Article (PDF)-8140K (230)
|
Full Article with Cover (PDF)-8392K (148)
|
Full Article (XML)-121K (99)
|
Audio-885K (43)
|
Peer-Review Report-197K (107)
|
Answering Reviewers-155K (119)
|
Supplementary Material-123K (95)
|
Received: 08/16/2024
|
Revised: 12/11/2024
|
Accepted: 02/10/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (7640)
|
Similar Articles (19)
|
Timeline of Article Publication (11)
|
Authors Evaluation (7)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
World J Gastroenterol
31(10):102393.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102393
Abstract (483)
|
Core Tip (614)
|
Full Article (HTML) (1809)
|
Figures (1-2) (417)
|
Tables (1-3) (383)
|
Full Article (PDF)-3168K (203)
|
Full Article with Cover (PDF)-3422K (165)
|
Full Article (XML)-97K (98)
|
Audio-586K (51)
|
Peer-Review Report-221K (123)
|
Answering Reviewers-311K (93)
|
Supplementary Material-128K (104)
|
Received: 10/16/2024
|
Revised: 01/04/2025
|
Accepted: 02/08/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (8)
|
Total Visits (6596)
|
Similar Articles (3)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Circular RNA contributes to gastric cancer by targeting Wnt family member 2B as a competing endogenous RNA
World J Gastroenterol
31(10):99583.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.99583
Abstract (469)
|
Core Tip (499)
|
Full Article (HTML) (1475)
|
Figures (1-6) (377)
|
Full Article (PDF)-10367K (160)
|
Full Article with Cover (PDF)-10622K (155)
|
Full Article (XML)-108K (97)
|
Audio-200K (12)
|
Peer-Review Report-203K (93)
|
Answering Reviewers-316K (133)
|
Received: 10/23/2024
|
Revised: 12/26/2024
|
Accepted: 01/23/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (4661)
|
Similar Articles (1285)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Platelet activation relieves liver portal hypertension via the lymphatic system though the classical vascular endothelial growth factor receptor 3 signaling pathway
World J Gastroenterol
31(10):100194.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100194
Abstract (463)
|
Core Tip (462)
|
Full Article (HTML) (2047)
|
Figures (1-8) (449)
|
Full Article (PDF)-42475K (206)
|
Full Article with Cover (PDF)-42729K (180)
|
Full Article (XML)-113K (105)
|
Audio-352K (27)
|
Peer-Review Report-309K (85)
|
Answering Reviewers-116K (88)
|
Supplementary Material-190K (97)
|
Received: 08/09/2024
|
Revised: 12/16/2024
|
Accepted: 01/21/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (5755)
|
Similar Articles (145)
|
Timeline of Article Publication (12)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Lactococcus garvieae aggravates cholestatic liver disease by increasing intestinal permeability and enhancing bile acid reabsorption
World J Gastroenterol
31(10):101014.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.101014
Abstract (461)
|
Core Tip (512)
|
Full Article (HTML) (1957)
|
Figures (1-6) (377)
|
Tables (1-1) (413)
|
Full Article (PDF)-10815K (190)
|
Full Article with Cover (PDF)-11065K (167)
|
Full Article (XML)-143K (98)
|
Audio-400K (38)
|
Peer-Review Report-253K (86)
|
Answering Reviewers-98K (88)
|
Supplementary Material-270K (98)
|
Received: 09/03/2024
|
Revised: 12/19/2024
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (7434)
|
Similar Articles (19)
|
Timeline of Article Publication (5)
|
Authors Evaluation (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
SEL1L-mediated endoplasmic reticulum associated degradation inhibition suppresses proliferation and migration in Huh7 hepatocellular carcinoma cells
World J Gastroenterol
31(10):103133.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103133
Abstract (492)
|
Core Tip (523)
|
Full Article (HTML) (1877)
|
Figures (1-7) (431)
|
Full Article (PDF)-9623K (196)
|
Full Article with Cover (PDF)-9876K (149)
|
Full Article (XML)-121K (115)
|
Audio-824K (24)
|
Peer-Review Report-275K (111)
|
Answering Reviewers-363K (120)
|
Supplementary Material-48K (94)
|
Received: 11/10/2024
|
Revised: 01/04/2025
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5738)
|
Similar Articles (1865)
|
Timeline of Article Publication (10)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Nab-paclitaxel plus capecitabine as a first-line regimen for advanced biliary tract cancers: Feasible or not feasible?
World J Gastroenterol
31(10):100771.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100771
Abstract (443)
|
Core Tip (486)
|
Full Article (HTML) (1052)
|
Figures (1-1) (399)
|
Tables (1-2) (413)
|
Full Article (PDF)-471K (116)
|
Full Article with Cover (PDF)-728K (90)
|
Full Article (XML)-61K (105)
|
Audio-512K (27)
|
Peer-Review Report-257K (83)
|
Answering Reviewers-156K (87)
|
Received: 08/25/2024
|
Revised: 01/10/2025
|
Accepted: 02/10/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4212)
|
Similar Articles (25)
|
Timeline of Article Publication (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):102580.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102580
Abstract (544)
|
Core Tip (590)
|
Full Article (HTML) (1992)
|
Tables (1-1) (487)
|
Full Article (PDF)-370K (158)
|
Full Article with Cover (PDF)-625K (176)
|
Full Article (XML)-56K (102)
|
Audio-2970K (19)
|
Peer-Review Report-217K (92)
|
Answering Reviewers-149K (93)
|
Received: 10/22/2024
|
Revised: 01/16/2025
|
Accepted: 02/08/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (5179)
|
Similar Articles (178)
|
Timeline of Article Publication (3)
|
Authors Evaluation (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):102725.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102725
Abstract (556)
|
Core Tip (510)
|
Full Article (HTML) (4126)
|
Figures (1-1) (400)
|
Full Article (PDF)-1500K (204)
|
Full Article with Cover (PDF)-1754K (161)
|
Full Article (XML)-97K (96)
|
Audio-476K (26)
|
Peer-Review Report-468K (88)
|
Answering Reviewers-1818K (105)
|
Received: 10/27/2024
|
Revised: 01/16/2025
|
Accepted: 01/23/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (13)
|
Total Visits (7423)
|
Similar Articles (317)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Treatment of intermediate-to-advanced unresectable hepatocellular carcinoma is shifting toward a multidisciplinary strategy that includes multiple modalities as needed
World J Gastroenterol
31(10):103420.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103420
Abstract (443)
|
Core Tip (488)
|
Full Article (HTML) (2034)
|
Figures (1-1) (358)
|
Tables (1-1) (414)
|
Full Article (PDF)-578K (152)
|
Full Article with Cover (PDF)-834K (202)
|
Full Article (XML)-91K (101)
|
Audio-833K (26)
|
Peer-Review Report-243K (95)
|
Answering Reviewers-100K (96)
|
Received: 11/18/2024
|
Revised: 01/31/2025
|
Accepted: 02/12/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5534)
|
Similar Articles (1865)
|
Timeline of Article Publication (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):103973.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103973
Abstract (490)
|
Core Tip (542)
|
Full Article (HTML) (4789)
|
Full Article (PDF)-406K (380)
|
Full Article with Cover (PDF)-661K (190)
|
Full Article (XML)-95K (108)
|
Audio-989K (45)
|
Peer-Review Report-215K (82)
|
Answering Reviewers-118K (90)
|
Received: 12/05/2024
|
Revised: 01/24/2025
|
Accepted: 02/11/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (7799)
|
Similar Articles (3)
|
Timeline of Article Publication (2)
|
Authors Evaluation (4)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Two treatment methods for hepatocellular carcinoma: Lenvatinib or bevacizumab combined with sintilimab and interventional therapy
World J Gastroenterol
31(10):104429.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.104429
Abstract (501)
|
Core Tip (430)
|
Full Article (HTML) (1405)
|
Tables (1-1) (377)
|
Full Article (PDF)-366K (149)
|
Full Article with Cover (PDF)-621K (162)
|
Full Article (XML)-45K (94)
|
Audio-1658K (24)
|
Peer-Review Report-175K (74)
|
Answering Reviewers-38K (81)
|
Received: 12/19/2024
|
Revised: 01/13/2025
|
Accepted: 01/24/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4444)
|
Similar Articles (1922)
|
Timeline of Article Publication (4)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
